|
1
|
Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients.
|
Pharmacogenet Genomics
|
2009
|
1.41
|
|
2
|
Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
|
Clin Exp Pharmacol Physiol
|
2011
|
0.91
|
|
3
|
Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
|
Eur J Pharmacol
|
2009
|
0.89
|
|
4
|
Influence of GGCX genotype on warfarin dose requirements in Chinese patients.
|
Thromb Res
|
2010
|
0.87
|